Establishment of Biopharmaceutical and Animal Vaccine Production Capacity in Thailand and Neighboring South East Asian Countries

Funded by a total of Pound 3.93 million for a period of 4 years from the Global Challenges Research Fund (GCRF), the project brings together UK and Thai experts to establish facilities and technology for recombinant protein production in Thailand, especially biopharmaceuticals and animal vaccines.

Biopharmaceuticals are revolutionizing the world of medicine and saving the lives of thousands of people. Patients suffering from cancer, diabetes, inflammatory diseases and other health problems benefit from biopharmaceuticals’ high efficacy and few side effects. The efficacy and safety of biopharmaceutical products dictate pharma companies to command high prices for their innovative drugs which, unfortunately, hinder patient access in developing countries such as Thailand.

Veterinary vaccines are important for animal health, animal welfare and food production. The burden of infectious diseases in livestock is a major constraint to sustained agricultural development and food security. Swine industry is massive in Thailand, with more than 200,000 households maintaining pigs. However, the industry continues to be plagued by viral epidemics. Thailand currently imports all of its animal vaccines but they are often ineffective as local viral strains are different.

To widely introduce the project to relevant stakeholders, the British Embassy in Bangkok hosted a showcase event for the consortium on November 28, 2018, with over 100 delegates from SE Asian institutions and companies.

The Global Challenges Research Fund (GCRF) is a Pound 1.5 billion fund announced by the UK Government in late 2015 to support cutting-edge research that addresses the challenges faced by developing countries (

Source: BIOTEC

Post Author: